To analyze the current healthcare landscape in India and determine the potential for CAR T cell therapy commercialization.
To identify and evaluate different strategic business models that can be implemented for the successful commercialization of CAR T cell therapy in India.
To assess the various market entry strategies that can be utilized to penetrate the Indian market effectively and gain a competitive advantage.
Conduct a thorough literature review on CAR T cell therapy and its potential for commercialization in India.
Analyze the healthcare market in India, including regulatory requirements, reimbursement policies, and competitive landscape.
Develop a SWOT analysis for the commercialization of CAR T cell therapy in India.
Propose strategic business models and market entry strategies for the successful commercialization of CAR T cell therapy in India.
Present findings and recommendations in a final research report.
